ArticleCancer management and research2022

Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland.

Jingxue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.